Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study oleh Balbir Singh, Yu-Cheng Hsieh, Yen-Bin Liu, Kuo-Hung Lin, Boyoung Joung, Diego A. Rodriguez, Alexandr R. Chasnoits, Dejia Huang, Shu Zhang, Janet E. O'Brien, Daniel R. Lexcen, Jeffrey Cerkvenik, Brian Van Dorn, Chi-Keong Ching